Skip to main content
LIGAND PHARMACEUTICALS INC logo

LIGAND PHARMACEUTICALS INC — Investor Relations & Filings

Ticker · LGND ISIN · US53220K5048 LEI · 5493008K7TB0IKP37H79 US Financial and insurance activities
Open in API
Filings indexed 1,392 across all filing types
Latest filing 2022-08-10 Capital/Financing Update
Country US United States of America
Listing US LGND

About LIGAND PHARMACEUTICALS INC

https://www.ligand.com/

Ligand Pharmaceuticals Incorporated is a biopharmaceutical company that functions as a capital and technology partner to the life sciences industry. The company's business model focuses on acquiring and developing royalty-generating assets by investing in the clinical development and commercialization of medicines. It manages a large, diverse portfolio of economic rights to partnered programs across therapeutic areas such as oncology, kidney disease, diabetes, and rare conditions. In addition to its royalty business, Ligand develops and licenses its proprietary technology platforms to a global network of biopharmaceutical partners. Its key technologies include Captisol®, a chemically modified cyclodextrin used to improve the solubility and stability of active pharmaceutical ingredients, and the NITRICIL™ platform.

Recent filings

Filing Released Lang Actions
S-8
Capital/Financing Update Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC, which registers securities for issuance under an employee benefit plan (the 2022 Employment Inducement Plan). It includes details about the plan, indemnification provisions, incorporation by reference of other filings, and exhibits. It is not a financial report like an Annual Report (10-K) or Quarterly Report (IR), nor is it an earnings release or management discussion. It is a registration statement related to securities issuance under an employee plan, which falls under capital/financing activities. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is the actual registration statement, not just an announcement or a certification, so it is not RPA or RNS.
2022-08-10 English
10-Q
Interim / Quarterly Report Q2 2022
2022-08-09 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 8, 2022, reporting the issuance of a press release announcing financial results for the three and six months ended June 30, 2022. The text explicitly states that the press release is furnished as an exhibit and that the Form 8-K is a current report. The document length is 3651 characters, which is relatively short and mainly serves as an announcement of the earnings release rather than containing the full financial results or detailed analysis. According to the rules, such a document announcing financial results but primarily consisting of a press release is classified as an Earnings Release (ER).
2022-08-08 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically discusses the approval of a new employment inducement plan by the Board of Directors, including details about stock awards and plan terms. This relates to changes in compensatory arrangements and board actions rather than a full financial report or earnings release. The document is not an annual or quarterly report, nor is it a transcript or dividend notice. It is a regulatory filing announcing a board-approved compensation plan. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length is about 4951 characters, which is consistent with a detailed regulatory announcement rather than a brief notice or full report.
2022-08-02 English
PRIMARY DOCUMENT
Director's Dealing
2022-07-07 English
PRIMARY DOCUMENT
Director's Dealing
2022-07-07 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.